A new study found that many patients who tapered their meds wound up flaring.
Time is of the essence when RA symptoms strike.
Held virtually, the 2020 medical meeting from the European League Against Rheumatism shared important medical breakthroughs and updates about managing rheumatic conditions.
Approved in 2019 for moderate to severe rheumatoid arthritis, the drug may offer an oral alternative to infused or injected biologics.
In a ‘head-to-head’ clinical trial, Cosentyx, an IL-17 inhibitor, cleared skin better than Humira and it did just as well treating joint problems.
It could be easy to mistake this pain for a tendon injury, but if it’s a gout flare, it will respond to gout treatment.
The difference may be patients’ prolonged exposure to anti-malarial drugs, new research suggests.
Prescribing higher doses of HCQ and adjusting the amount to reach a specific blood level target could help lupus patients avoid blood clots and related complications.
This research confirms the important role of high-intensity exercise in the treatment of axSpA, say study authors.
Could pain symptoms be improved in researchers assess patients’ pain perception as part of their treatment plan?